Therapeutic expertise.

Our vast experience in oncology harnesses a deep understanding of the latest advancements in cancer treatments. We’ve partnered with 111 innovators and have worked on 318 oncology assets, with 55 of them going on to become blockbuster therapies that achieved 87% market coverage.

Our extensive expertise in CNS treatments has seen us work with 72 partners to advance 131 of their assets, with 31 of them going on to become blockbuster therapies, achieving 40% market coverage.

With a wealth of knowledge in cardiology, we’ve helped 58 of our partners advance 70 assets further along the clinical and commercial journey.

We’ve supported 59 of our global partners in getting 42 gastroenterology assets closer to the market.

Our therapeutic expertise in immunology therapies has helped 45 of our partners maximize the value of 38 assets so far.

Alongside 62 partners, we’ve worked on 142 assets designed to assist the treatment of a wide range of dermatological conditions.

We have a comprehensive understanding of the diagnosis and treatment of pulmonary diseases, having served 68 partners in getting a total of 85 assets closer to patients.

Our team of experts has supported in the development of therapies for a wide range of infectious diseases, serving 95 of our partners across 145 assets.

We bring extensive knowledge and expertise in the treatment of endocrine disorders, having served 45 of our partners on 59 assets.

Our team harnesses in-depth knowledge in the treatment of a range of musculoskeletal disorders, serving 46 partners with 49 assets.